EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis.
The development of multiple sclerosis is most likely influenced by autoimmune responses to central nervous system myelin proteins as well as by infections with common viruses such as EBV and human herpesvirus-6. However, much remains to be established on how these factors interact. In this study, we show that upon EBV infection, human B cells start to express alpha B-crystallin, a small stress protein that was identified previously as an immunodominant Ag of CNS myelin in multiple sclerosis patients. EBV-induced expression of alpha B-crystallin in B cells leads to HLA-DR-restricted presentation of the protein and to activation of proinflammatory alpha B-crystallin-specific Th cells. While alpha B-crystallin is present in EBV-infected human B cells, the protein is absent from human lymphoid tissues under normal conditions. This is in sharp contrast to other stress proteins such as heat-shock protein (hsp)27 and hsp60 that are ubiquitously expressed in these tissues. In addition, the absence of alpha B-crystallin from lymphoid tissues in humans is unique as compared with other mammals. All other species examined, including rodents, sheep, and primates, showed constitutive expression of alpha B-crystallin in secondary lymphoid tissues and sometimes even in the thymus. Since constitutive lymphoid expression most likely results in immunologic tolerance, such a state of tolerance to alpha B-crystallin can be expected for all of these species, but not for humans. When taken together, our data provide evidence for a novel mechanism by which common viral infections can trigger myelin-directed autoimmunity in a way that is unique for humans.
van Sechel
A C
AC
Division of Immunological and Infectious Diseases, TNO Prevention and Health, Leiden, The Netherlands.
Bajramovic
J J
JJ
van Stipdonk
M J
MJ
Persoon-Deen
C
C
Geutskens
S B
SB
van Noort
J M
JM
D000818:Animals; D017951:Antigen Presentation; D001324:Autoantigens / Q000378:metabolism*; D016175:B-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism* / Q000821:virology; D002461:Cell Line, Transformed; D002472:Cell Transformation, Viral / Q000276:immunology; D003459:Crystallins / Q000096:biosynthesis* / Q000276:immunology / Q000378:metabolism; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D005260:Female; D006684:HLA-DR Antigens / Q000276:immunology*; D006360:Heat-Shock Proteins / Q000096:biosynthesis; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D008221:Lymphoid Tissue / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009103:Multiple Sclerosis / Q000276:immunology*; D011323:Primates; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D012756:Sheep; D016176:T-Lymphocyte Subsets / Q000276:immunology
D001324:Autoantigens; D003459:Crystallins; D018984:Epitopes, T-Lymphocyte; D006684:HLA-DR Antigens; D006360:Heat-Shock Proteins